SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla shines on reporting 21% rise in Q1 consolidated net profit

10 Aug 2020 Evaluate

Cipla is currently trading at Rs. 803.30, up by 74.70 points or 10.25% from its previous closing of Rs. 728.60 on the BSE.

The scrip opened at Rs. 763.40 and has touched a high and low of Rs. 806.50 and Rs. 751.55 respectively. So far 882262 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 806.50 on 10-Aug-2020 and a 52 week low of Rs. 356.75 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 806.50 and Rs. 700.90 respectively. The current market cap of the company is Rs. 64343.39 crore.

The promoters holding in the company stood at 36.68%, while Institutions and Non-Institutions held 39.92% and 23.40% respectively.

Cipla has reported a fall of 12.06% in its net profit at Rs 610.30 crore for the quarter ended June 30, 2020 as compared to Rs 694.00 crore for the same quarter in the previous year. Total income of the company decreased by 4.49% at Rs 3,173.68 crore for Q1FY21 as compared Rs 3,322.74 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 20.85% in its net profit attributable to shareholders at Rs 577.91 crore for the quarter ended June 30, 2020 as compared to Rs 478.19 crore for the same quarter in the previous year. Total income of the company increased by 8.46% at Rs 4,411.61 crore for Q1FY21 as compared Rs 4,067.39 crore for the corresponding quarter previous year.

Cipla Share Price

1438.75 -2.95 (-0.20%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: